Key facts
- Joe Lonsdale filed SCHEDULE 13G/A for Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI).
- Disclosed ownership: 1%.
- Date of event: 31 Mar 2025.
Joe Lonsdale - 31 Mar 2025 SCHEDULE 13G/A Report for Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI)
- Filing Manager
- Joe Lonsdale
- Reporting Manager
- 8VC GP I, LLC
- Symbol
- SNTI
- Shares outstanding
- 25,375,500 shares
- Disclosed Ownership
- 253,755 shares
- Ownership
- 1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 May 2025, 16:26:36 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Key filing fact
Joe Lonsdale disclosed 1% ownership in Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI) on 31 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 May 2025, 16:26.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (4)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 8VC Fund I, L.P. | 1% | 249,827 | 0 | 249,827 | /s/ Joe Lonsdale | Joe Lonsdale, Managing Member of 8VC GP I, LLC, the general partner of 8VC Fund I, L.P. | |
| 8VC Entrepreneurs Fund I, L.P. | 0% | 3,928 | 0 | 3,928 | /s/ Joe Lonsdale | Joe Lonsdale, Managing Member of 8VC GP I, LLC, the general partner of 8VC Entrepreneurs Fund I, L.P. | |
| 8VC GP I, LLC | 1% | 253,755 | 0 | 253,755 | /s/ Joe Lonsdale | Joe Lonsdale, Managing Member | |
| Joe Lonsdale | 1% | 253,755 | 253,755 | 0 | /s/ Joe Lonsdale | Joe Lonsdale |
CIK / CUSIP context first